Study: Targeted drug combos block tumor cell growth

09/13/2007 | ScientificAmerican.com

A combination of targeted cancer drugs, also known as receptor tyrosine kinases, can outsmart tumor cells by preventing protein switches from inciting cell growth, U.S. researchers report. However, scientists said further studies are needed before the combination treatments can be recommended to cancer patients, given the drugs' possible toxicity risk and high cost.

View Full Article in:

ScientificAmerican.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX